Literature DB >> 10858199

The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis.

F N Lauw1, A J Simpson, J M Prins, S J van Deventer, W Chaowagul, N J White, T van der Poll.   

Abstract

Gamma interferon (IFN-gamma)-inducible protein 10 (IP-10) and monokine induced by IFN-gamma (Mig) are related CXC chemokines which bind to the CXCR3 receptor and specifically target activated T lymphocytes and natural killer (NK) cells. The production of IP-10 and Mig by various cell types in vitro is strongly dependent on IFN-gamma. To determine whether IP-10 and Mig are released during bacterial infection in humans, we measured plasma levels of IP-10 and Mig in patients with melioidosis, a severe gram-negative infection caused by Burkholderia pseudomallei. IP-10 and Mig were markedly elevated in patients with melioidosis on admission, particularly in blood culture-positive patients, and remained elevated during the 72-h study period. Levels of IP-10 and Mig showed a positive correlation with IFN-gamma concentrations and also correlated with clinical outcome. In whole blood stimulated with heat-killed B. pseudomallei, neutralization of IFN-gamma and tumor necrosis factor alpha (TNF-alpha) partly attenuated IP-10 and Mig release, while anti-interleukin-12 (IL-12) and anti-IL-18 had a synergistic effect. Stimulation with other bacteria or endotoxin also induced strong secretion of IP-10 and Mig. These data suggest that IP-10 and Mig are part of the innate immune response to bacterial infection. IP-10 and Mig may contribute to host defense in Th1-mediated host defense during infections by attracting CXCR3(+) Th1 cells to the site of inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858199      PMCID: PMC101663          DOI: 10.1128/IAI.68.7.3888-3893.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions.

Authors:  M Goebeler; A Toksoy; U Spandau; E Engelhardt; E B Bröcker; R Gillitzer
Journal:  J Pathol       Date:  1998-01       Impact factor: 7.996

2.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.

Authors:  S Qin; J B Rottman; P Myers; N Kassam; M Weinblatt; M Loetscher; A E Koch; B Moser; C R Mackay
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

Review 3.  Chemokines--chemotactic cytokines that mediate inflammation.

Authors:  A D Luster
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

Review 4.  Chemokines.

Authors:  B J Rollins
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

5.  The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells.

Authors:  A Sauty; M Dziejman; R A Taha; A S Iarossi; K Neote; E A Garcia-Zepeda; Q Hamid; A D Luster
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

6.  Involvement of the IP-10 chemokine in sarcoid granulomatous reactions.

Authors:  C Agostini; M Cassatella; R Zambello; L Trentin; S Gasperini; A Perin; F Piazza; M Siviero; M Facco; M Dziejman; M Chilosi; S Qin; A D Luster; G Semenzato
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

7.  Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1.

Authors:  F Lahrtz; L Piali; D Nadal; H W Pfister; K S Spanaus; M Baggiolini; A Fontana
Journal:  Eur J Immunol       Date:  1997-10       Impact factor: 5.532

8.  The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor.

Authors:  C S Tannenbaum; R Tubbs; D Armstrong; J H Finke; R M Bukowski; T A Hamilton
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

9.  Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.

Authors:  F Sallusto; D Lenig; C R Mackay; A Lanzavecchia
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

10.  Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.

Authors:  K E Cole; C A Strick; T J Paradis; K T Ogborne; M Loetscher; R P Gladue; W Lin; J G Boyd; B Moser; D E Wood; B G Sahagan; K Neote
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  22 in total

Review 1.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

2.  Isolation of scFv fragments specific for monokine induced by interferon-gamma (MIG) using phage display.

Authors:  Edward Eteshola
Journal:  J Immunol Methods       Date:  2010-04-09       Impact factor: 2.303

3.  Consumption of rice bran increases mucosal immunoglobulin A concentrations and numbers of intestinal Lactobacillus spp.

Authors:  Angela J Henderson; Ajay Kumar; Brittany Barnett; Steven W Dow; Elizabeth P Ryan
Journal:  J Med Food       Date:  2012-01-16       Impact factor: 2.786

Review 4.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

5.  Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.

Authors:  Angela Henderson; Katie Propst; Ross Kedl; Steven Dow
Journal:  Vaccine       Date:  2011-05-19       Impact factor: 3.641

6.  CXCL16 regulates cell-mediated immunity to Salmonella enterica serovar Enteritidis via promotion of gamma interferon production.

Authors:  Olivier L Fahy; Scott L Townley; Shaun R McColl
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

7.  Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli.

Authors:  Matthew A Crawford; Yinghua Zhu; Candace S Green; Marie D Burdick; Patrick Sanz; Farhang Alem; Alison D O'Brien; Borna Mehrad; Robert M Strieter; Molly A Hughes
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

8.  Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.

Authors:  Surasakdi Wongratanacheewin; Wannapa Kespichayawattana; Pakamas Intachote; Sathit Pichyangkul; Rasana W Sermswan; Arthur M Krieg; Stitaya Sirisinha
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infection.

Authors:  S Raghavan; J Nyström; M Fredriksson; J Holmgren; A M Harandi
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Reduced interferon-gamma release in patients recovered from Legionnaires' disease.

Authors:  K D Lettinga; S Weijer; P Speelman; J M Prins; T Van Der Poll; A Verbon
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.